Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis

BACKGROUND: Ewing sarcoma patients have a poor prognosis despite multimodal therapy. Integration of combination immunotherapeutic strategies into first-/second-line regimens represents promising treatment options, particularly for patients with intrinsic or acquired resistance to conventional therap...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Berghuis, Dagmar, Schilham, Marco W, Vos, Hanneke I, Santos, Susy J, Kloess, Stephan, Buddingh', Emilie P, Egeler, R Maarten, Hogendoorn, Pancras CW, Lankester, Arjan C
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3351702/
https://ncbi.nlm.nih.gov/pubmed/22587892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2045-3329-2-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados